Trial Profile
Regional Transplant Programs Study of Immunosuppressive Therapy Related Toxicities in Renal Transplant Recipients Managed at Regional or Satellite Community Nephrology Clinics.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2014
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Ciclosporin; Immunosuppressants
- Indications Renal transplant rejection
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 29 May 2009 New trial record